+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Structural Heart Devices - Global Market Trajectory & Analytics

  • ID: 4805257
  • Report
  • April 2021
  • Region: Global
  • 114 Pages
  • Global Industry Analysts, Inc
Global Structural Heart Devices Market to Reach $18 Billion by 2027

Amid the COVID-19 crisis, the global market for Structural Heart Devices estimated at US$9.9 Billion in the year 2020, is projected to reach a revised size of US$18 Billion by 2027, growing at a CAGR of 8.9% over the analysis period 2020-2027. Heart Valve Devices, one of the segments analyzed in the report, is projected to record a 9.9% CAGR and reach US$7.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Surgical Heart Valves segment is readjusted to a revised 9.2% CAGR for the next 7-year period.



The U.S. Market is Estimated at $2.9 Billion, While China is Forecast to Grow at 8.2% CAGR

The Structural Heart Devices market in the U.S. is estimated at US$2.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.1 Billion by the year 2027 trailing a CAGR of 8.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.3% and 7.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.1% CAGR.

Transcatheter Heart Valves Segment to Record 8.5% CAGR

In the global Transcatheter Heart Valves segment, USA, Canada, Japan, China and Europe will drive the 8.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.2 Billion in the year 2020 will reach a projected size of US$2.2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.1 Billion by the year 2027.

Select Competitors (Total 42 Featured):
  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Braile Biomedica
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • LivaNova PLC
  • Medtronic PLC
  • Micro Interventional Devices, Inc.
  • TTK Healthcare Ltd.
Frequently Asked Questions about the Global Market for Structural Heart Devices

What is the estimated value of the Global Market for Structural Heart Devices?

The Global Market for Structural Heart Devices was estimated to be valued at $9.9 Billion in 2020.

What is the growth rate of the Global Market for Structural Heart Devices?

The growth rate of the Global Market for Structural Heart Devices is 8.9%, with an estimated value of $18.0 Billion by 2027.

What is the forecasted size of the Global Market for Structural Heart Devices?

The Global Market for Structural Heart Devices is estimated to be worth $18.0 Billion by 2027.
Note: Product cover images may vary from those shown

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Current & Future Analysis for Structural Heart Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 2: World 7-Year Perspective for Structural Heart Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
  • Table 3: World Current & Future Analysis for Heart Valve Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 4: World 7-Year Perspective for Heart Valve Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 5: World Current & Future Analysis for Surgical Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 6: World 7-Year Perspective for Surgical Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 7: World Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 8: World 7-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 9: World Current & Future Analysis for Occluders and Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 10: World 7-Year Perspective for Occluders and Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 11: World Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 12: World 7-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

III. MARKET ANALYSIS
  • UNITED STATES
  • Table 13: USA Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders and Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 14: USA 7-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders and Delivery Systems and Other Products for the Years 2020 & 2027
  • CANADA
  • Table 15: Canada Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders and Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 16: Canada 7-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders and Delivery Systems and Other Products for the Years 2020 & 2027
  • JAPAN
  • Table 17: Japan Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders and Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 18: Japan 7-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders and Delivery Systems and Other Products for the Years 2020 & 2027
  • CHINA
  • Table 19: China Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders and Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 20: China 7-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders and Delivery Systems and Other Products for the Years 2020 & 2027
  • EUROPE
  • Table 21: Europe Current & Future Analysis for Structural Heart Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 22: Europe 7-Year Perspective for Structural Heart Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
  • Table 23: Europe Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders and Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 24: Europe 7-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders and Delivery Systems and Other Products for the Years 2020 & 2027
  • FRANCE
  • Table 25: France Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders and Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 26: France 7-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders and Delivery Systems and Other Products for the Years 2020 & 2027
  • GERMANY
  • Table 27: Germany Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders and Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 28: Germany 7-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders and Delivery Systems and Other Products for the Years 2020 & 2027
  • ITALY
  • Table 29: Italy Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders and Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 30: Italy 7-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders and Delivery Systems and Other Products for the Years 2020 & 2027
  • UNITED KINGDOM
  • Table 31: UK Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders and Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 32: UK 7-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders and Delivery Systems and Other Products for the Years 2020 & 2027
  • REST OF EUROPE
  • Table 33: Rest of Europe Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders and Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 34: Rest of Europe 7-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders and Delivery Systems and Other Products for the Years 2020 & 2027
  • ASIA-PACIFIC
  • Table 35: Asia-Pacific Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders and Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 36: Asia-Pacific 7-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders and Delivery Systems and Other Products for the Years 2020 & 2027
  • REST OF WORLD
  • Table 37: Rest of World Current & Future Analysis for Structural Heart Devices by Product - Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders and Delivery Systems and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 38: Rest of World 7-Year Perspective for Structural Heart Devices by Product - Percentage Breakdown of Value Sales for Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders and Delivery Systems and Other Products for the Years 2020 & 2027

IV. COMPETITION
  • Total Companies Profiled: 42
Note: Product cover images may vary from those shown